TherapeuticsMD

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$234
$313
$502
$-53
Gross Profit
54
180
-135
-183
EBITDA
-999
-1,008
-974
-1,284
EBIT
-1,179
-1,141
-1,611
-1,414
Net Income
-1,090
-734
-883
-3,378
Net Change In Cash
234
313
502
-53
Free Cash Flow
894
11
-7,841
-6,028
Cash
5,232
4,338
4,327
10,166
Basic Shares
11,532
11,532
11,532
10,701

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$1,302
$69,963
$86,951
$64,872
Gross Profit
380
68,566
68,113
48,897
EBITDA
-8,401
21,328
-135,405
-150,876
EBIT
-8,523
20,135
-136,141
-156,348
Net Income
-10,278
111,997
-205,604
-212,702
Net Change In Cash
1,302
69,963
86,951
64,872
Cost of Revenue
-15,364
-80,343
Free Cash Flow
-48,141
-4,433
-144,916
-161,068
Cash
4,327
38,067
65,122
80,485
Basic Shares
10,441
9,028
7,960
5,512

Earnings Calls

Quarter EPS
2024-06-30
-$0.09
2024-03-31
-$0.07
2023-12-31
-$0.08
2023-09-30
-$0.32